ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Charlotte, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Charlotte, NC, USA:

Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC) (ELITE)

(Dehydrated Human Placental Tissue) Product and Standard of Care work when compared to Standard of Care alone in achieving complete closure of diabetic...

Enrolling
Diabetic Foot Ulcer
Other: Amnion-Intermediate-Chorion
Procedure: Standard of Care (SOC)

Phase 4

Cellution Biologics

Mooresville, North Carolina, United States and 7 other locations

This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus....

Enrolling
Diabetes Mellitus, Type 1
Drug: Cadisegliatin 800 mg QD
Drug: Placebo

Phase 3

vTv Therapeutics
vTv Therapeutics

Charlotte, North Carolina, United States and 49 other locations

The goal of this clinical trial is to learn if using perinatal tissue allografts improves healing of chronic, non-healing foot ulcers in diabetic...

Enrolling
Diabetic Foot Ulcer
Other: Three-layer fenestrated perinatal tissue allograft
Other: Dual-layer perinatal tissue allograft
Samaritan Biologics

Monroe, North Carolina, United States of America

This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, co...

Active, not recruiting
Diabetes Mellitus, Type 2
Diabetic Peripheral Neuropathy
Drug: CagriSema (Cagrilintide B and Semaglutide I)
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Phase 2

Novo Nordisk
Novo Nordisk

Statesville, North Carolina, United States and 54 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Charlotte, North Carolina, United States of America and 228 other locations

Study GR41675 is a Multicenter, Randomized Study in Participants with Diabetic Retinopathy (DR) Without Center-Involved Diabetic Ma...

Active, not recruiting
Diabetic Retinopathy
Drug: PDS Implant Pre-Filled with 100 mg/mL Ranibizumab
Drug: Intravitreal Ranibizumab 0.5 mg Injection

Phase 3

Roche
Roche

Charlotte, North Carolina, United States and 76 other locations

study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or obesity and type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Overweight
Other: Placebo
Drug: Petrelintide

Phase 2

Zealand Pharma
Zealand Pharma

Charlotte, North Carolina, United States and 48 other locations

control in participants with obesity or with overweight and type 2 diabetes. This trial is part of the master protocol study J2A-MC-GZPO.Par...

Enrolling
Type 2 Diabetes
Overweight
Drug: Orforglipron
Drug: Placebo

Phase 3

Lilly
Lilly

Charlotte, North Carolina, United States and 77 other locations

This study is being done to look at the effect and safety of different doses of NNC0662-0419 in people living with type 2 diabetes when comp...

Begins enrollment this month
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: NNC0662-0419

Phase 2

Novo Nordisk
Novo Nordisk

Statesville, North Carolina, United States and 62 other locations

participants who have obesity or overweight with or without type 2 diabetes. Participants will be screened for about 4 weeks, after which th...

Enrolling
Type 2 Diabetes
Overweight
Drug: Placebo
Drug: Orforglipron

Phase 3

Lilly
Lilly

Charlotte, North Carolina, United States and 80 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems